Clinical Trials on Fatty Liver in Switzerland
Total 219 results
-
University Hospital, Basel, SwitzerlandCompletedNon Alcoholic Fatty Liver Disease | Non Alcoholic SteatohepatitisSwitzerland
-
University of ZurichRecruiting
-
University Hospital, GenevaCompletedObesity | Non-alcoholic Fatty Liver Disease (NAFLD)Switzerland
-
University Hospital, Basel, SwitzerlandCompletedObesity | Non-alcoholic Fatty Liver DiseaseSwitzerland
-
University of LausanneCompletedObesity | Non-alcoholic Fatty Liver DiseaseSwitzerland
-
University of ZurichCompletedNon-alcoholic Steatohepatitis (NASH)Switzerland
-
University of LausanneNestlé Research Center, Vers-chez-les-blanc, SwitzerlandCompletedHepatic SteatosisSwitzerland
-
Xinhua Hospital, Shanghai Jiao Tong University...The First Affiliated Hospital with Nanjing Medical University; The First Hospital... and other collaboratorsRecruitingNon-alcoholic Fatty Liver DiseaseChina, Switzerland
-
Yaqrit LtdAssistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaboratorsWithdrawnNon-Alcoholic SteatohepatitisFrance, Italy, Portugal, Spain, Switzerland, United Kingdom
-
University of ZurichCompletedFatty Liver | SurgerySwitzerland
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo...
-
Astellas Pharma IncCompletedNon-Alcoholic SteatohepatitisUnited Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis NASHUnited Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
University of Lausanne HospitalsSalk Institute for Biological StudiesCompletedObesity | Metabolic Syndrome | Dyslipidemias | Glucose Intolerance | Eating Behavior | Steatosis of LiverSwitzerland
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Inventiva PharmaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
University of ZurichCompleted
-
University Hospital Inselspital, BerneTerminatedLiver Failure | Liver ResectionSwitzerland
-
University of ZurichUniversity Ghent; University Hospital of Sao Paulo, BrazilCompleted
-
Centre Hospitalier Universitaire VaudoisUniversity of ZurichUnknown
-
University Hospital Inselspital, BerneUniversity of BernTerminatedLiver NeoplasmSwitzerland
-
University of ZurichUnknownLiver Neoplasms | Liver RegenerationSwitzerland
-
University of ZurichCompletedColorectal Liver MetastasesSwitzerland
-
University of ZurichRecruitingLiver Diseases | Pancreas DiseaseSwitzerland
-
Novartis PharmaceuticalsCompletedLiver TransplantSwitzerland
-
University of BernCompleted
-
Dr.med. Monica RusticeanuUniversity Hospital Inselspital, Berne; University of BernTerminated
-
Swiss Group for Clinical Cancer ResearchCompletedLiver CancerSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedLiver CirrhosisSwitzerland
-
Helen Kovari-KramerSwiss HIV Cohort StudyUnknownHIV Infection and Chronic Alanine Aminotransferase ElevationSwitzerland
-
University Hospital Inselspital, BerneCompletedAdult Liver CancerSwitzerland
-
University Hospital, GenevaCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingLiver Failure | Acute-On-Chronic Liver Failure | Liver Disease | Cirrhosis of the LiverSwitzerland, United Kingdom
-
University of ZurichCompleted
-
NovartisCompletedLiver Transplantation | Kidney TransplantationSwitzerland
-
Sequana Medical N.V.RecruitingLiver Cirrhoses | Malignant AscitesGermany, Switzerland